HOME >> MEDICINE >> NEWS
Novel antibiotic shows promise in shortening treatment duration of tuberculosis

December 9, 2004 - Scientists at Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) have identified a novel anti-tuberculosis (TB) compound that works better and faster than the current standard of care in mouse models of TB infection. Also, preliminary studies in healthy human volunteers show that the drug is safe. The findings are published in the December 9 issue of Science Express, the online version of the journal Science, and will be published in the January 14 print edition. The studies are reported by scientists at J&JPRD and colleagues at the Swedish Institute for Infectious Disease Control in Solna, Sweden, and Piti-Salptrire School of Medicine in Paris, France.

The compound, called R207910, belongs to a new family of anti-TB agents called diarylquinolines (DARQ) and appears to have better, and more differentiated antibiotic properties than currently used drugs for TB, individually and in combination. R207910 was better at clearing infection from the lungs of mice than the triple cocktail regimen currently recommended by the World Health Organization (WHO). Also, cocktail regimens containing R207910 cleared infection in mice in half the time than the currently used regimen.

"The drug acts through a novel mechanism of action, and is therefore active against all multi-drug resistant (MDR) strains of TB tested so far," says Dr. Koen Andries, D.V.M., Ph.D., Distinguished Research Fellow, Antimicrobial Research at J&JPRD. "A combination including R207910 but excluding rifampin, one of the current TB drugs, looks especially promising. A combination excluding rifampin would be compatible with anti-HIV drugs, making it suitable for treating patients co-infected with HIV and TB."

The World Health Organization (WHO) has declared TB a global health crisis. TB now infects one-third of the world's population and causes close to nine million new cases of active TB and 2 million deaths each year. Unfortunately, many TB strains h
'"/>


9-Dec-2004


Page: 1 2 3 4

Related medicine news :

1. Novel therapy tested in mice could chase away cat allergies
2. Novel p53 gene-based therapy boosts immune system and reduces tumor size
3. Novel drugs help solve Gleevec resistance
4. Novel imaging technique shows abnormal brain anatomy in children with ADHD
5. Novel drug-antidote strategy provides greater control of drug action
6. Novel imaging technique shows lymph nodes, metastases in breast cancer without surgery
7. Novel delivery method for nutrients wins Kaye Innovation Award for Hebrew university students
8. Novel vitamin discovery offers clues for cancer chemotherapy and lipid disorders
9. Novel findings about neovessel formation
10. Novel MRI technique provides clear images of blood flow
11. Novelty-seeking teens may be more easily influenced by tobacco advertisements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2019)... ... December 06, 2019 , ... Brain Sentinel, ... Baltimore, Maryland at the AES Annual Meeting. The symposium, “Fundamentals of Quantitative Surface ... methods of quantitative sEMG analysis during ictal events;, 2. Review specific sEMG patterns ...
(Date:12/6/2019)... (PRWEB) , ... December 06, 2019 , ... Dr. Scott ... program, recently published research on the health benefits of coconut oil in the ... Intake and Its Effects on the Cardiometabolic Profile: A Structured Literature Review,” led by ...
(Date:12/5/2019)... (PRWEB) , ... December 05, 2019 , ... Abide, the ... over 25 million times this year using Bible-based bedtime stories. Listeners have recovered from ... , According to the Center for Disease Control, one third of Americans suffer from ...
(Date:12/5/2019)... ... December 05, 2019 , ... Intelligent.com, ... the Top 54 RHIT Degree Programs for 2020. The comprehensive research guide is ... Each program is evaluated based on curriculum quality, graduation rate, reputation, and post-graduate ...
(Date:12/5/2019)... ... 2019 , ... Today at M Health Fairview University of Minnesota ... who will to help them take medicine, relax during anxious moments, encourage them ... presented by NutriSource® is a golden retriever and the first and only full-time ...
Breaking Medicine News(10 mins):
(Date:12/4/2019)... ... December 04, 2019 , ... ... has announced the Top 17 Master's in Organizational Psychology Degree Programs for 2020. ... and universities in the nation. Each program is evaluated based on curriculum quality, ...
(Date:12/2/2019)... Kan. (PRWEB) , ... December 02, 2019 , ... ... XX, a nutritional supplement produced by Native Remedies aimed at supporting Women’s Fertility ... Unfortunately, Mother Nature makes conception harder for some women than for others. Factors ...
(Date:11/30/2019)... ... , ... Transpara™ 1.6, the leading Artificial Intelligence decision support ... potential breast cancer in 2D and 3D DBT mammograms, will be unveiled ... (ScreenPoint Medical, South Hall #4380). , The software uniquely ranks mammograms on a ...
Breaking Medicine Technology:
Cached News: